# reload+after+2024-01-22 19:45:03.615758
address1§5 Nahum Heftsadie Street
address2§Givaat Shaul PO Box 34670
city§Jerusalem
zip§91340
country§Israel
phone§972 2 659 5666
fax§972 2 659 5616
website§https://www.gamida-cell.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.
fullTimeEmployees§143
companyOfficers§[{'maxAge': 1, 'name': 'Ms. Abigail L. Jenkins', 'age': 47, 'title': 'President, CEO & Director', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 554053, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Michele Ilene Korfin M.B.A., R.Ph.', 'age': 51, 'title': 'Chief Operating & Chief Commercial Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 606000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ronit  Simantov M.D.', 'age': 58, 'title': 'Chief Medical Officer & Chief Scientific Officer', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 592000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Joshua F. Patterson', 'age': 46, 'title': 'General Counsel & Chief Compliance Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 479000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Mary Theresa Coelho M.B.A.', 'age': 61, 'title': 'CFO, Principal Financial Officer & Principal Accounting Officer', 'yearBorn': 1962, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Linda  Stamler', 'title': 'Vice President of Marketing & Account Management', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Penny  Bushell', 'title': 'Chief Human Resource Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Naftali  Brikashvili CPA', 'title': 'Senior Vice President Finance & Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tracey  Lodie Ph.D.', 'age': 53, 'title': 'Scientific Advisor & Consultant', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Vladimir  Melnikov', 'title': 'Senior Vice President of Global Operations & Manufacturing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.19
priceToSalesTrailing12Months§62.831074
currency§USD
dateShortInterest§1702598400
forwardEps§-0.56
exchange§NGM
quoteType§EQUITY
shortName§Gamida Cell Ltd.
longName§Gamida Cell Ltd.
firstTradeDateEpochUtc§1540560600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ff39c3c4-fc7a-3cce-8fdf-d4071894393b
gmtOffSetMilliseconds§-18000000
targetHighPrice§6.0
targetLowPrice§2.0
targetMeanPrice§4.0
targetMedianPrice§4.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§4
quickRatio§2.959
grossMargins§0.06984
ebitdaMargins§0.0
trailingPegRatio§None
